Rho (D) immune globulin
Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Suppression of Rh isoimmunization in non-sensitized, Rh o (D)-negative women to reduce likelihood of hemolytic disease in Rh o (D)-positive fetus in present and future pregnancies.
- Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rh o (D)-positive pts.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved